New injection MD-18 tested for weight loss in early human trial
Symptom relief
Recruiting now
This study is testing a new drug, MD-18, given as an injection under the skin, to see if it is safe and tolerable for healthy adults who are overweight or obese. The trial involves 54 participants and will monitor side effects, vital signs, and lab results. The goal is to gather …
Phase: PHASE1 • Sponsor: Cohen Global, Ltd. • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC